GlassScriptPhysician profile
Darria Marcella Lloyd
NPI 1831627355
$5,296.09
in general payments reported to CMS, 2019-2025
22 companies · $1,052 in 2025
The $1,052 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $595 · 2022: $1,214 · 2023: $952 · 2024: $1,483 · 2025: $1,052.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,388 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,388.15 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $776.77 | 2021-2025 | Carvykti, Darzalex, Tecvayli |
| Regeneron Healthcare Solutions, INC. | $727.54 | 2023-2024 | Libtayo |
| Seagen INC. | $525.60 | 2021-2023 | Adcetris |
| Incyte Corporation | $477.47 | 2022-2025 | Jakafi, Niktimvo |
| Legend Biotech USA INC. | $424.06 | 2023-2025 | Carvykti |
| Bayer Healthcare Pharmaceuticals INC. | $245.28 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $236.22 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $230.49 | 2022 | |
| Aveo Pharmaceuticals, INC. | $226.08 | 2021-2024 | |
| Emmaus Medical, INC. | $161.98 | 2022 | |
| Jazz Pharmaceuticals INC. | $147.03 | 2025 | |
| Blueprint Medicines Corporation | $134.99 | 2022 | |
| Amgen INC. | $132.37 | 2024 | Blincyto |
| Abbvie INC. | $125.00 | 2024 | |
| Genzyme Corporation | $124.99 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $122.99 | 2025 | |
| Astellas Pharma US INC | $120.29 | 2024 | Xospata |
| Beigene USA, INC. | $103.99 | 2022 | |
| Coloplast Corp | $88.13 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $82.07 | 2024 | Iclusig |
| Adaptive Biotechnologies Corporation | $43.75 | 2023 | Clonoseq |
| Atricure, INC. | $39.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darria Lloyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.